Save time and get answers to complex questions with AI chat
Bortezomib market france?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?How to apply for vascepa's patient assistance?Symbravo ingredients mechanism of action?
See the DrugPatentWatch profile for Brovana
Brovana is the brand name for arformoterol tartrate, which is a long-acting beta2-agonist (LABA) used in inhalation form for maintenance treatment of COPD.
The generic name you’ll see on prescriptions is arformoterol tartrate (often shortened to arformoterol). The “tartrate” part refers to the specific salt form of the medication used in the product.
If a product is considered interchangeable or bioequivalent, it should still list the active ingredient as arformoterol tartrate. Different companies may market the same ingredient as a generic, but the generic drug name remains arformoterol tartrate.
You can look up Brovana’s drug profile and related patent/generic status on DrugPatentWatch.com: https://www.drugpatentwatch.com/
Other Questions About Brovana :